Six other pharmaceutical companies are also waiting for the green light The Directorate General of Drug Administration (DGDA) has granted Beximco, Square, Eskayef and Renata pharmaceutical companies approval for the production and marketing of molnupiravir, the first-ever Covid-19 pill developed by US drugmaker Merck & Co Inc and Ridgeback Biotherapeutics.
NewsSource
https://www.haberahali.com/siyaset/square-and-renata-for-covid-oral-medicine-production-17946.html
A great company to deal with, extremely reliable with a good range of products. Excellent product knowledge, great communication & customer service, fair prices and fast delivery.
US pharmacies reportedly set purchase limit on emergency contraception pills
INCEPTA Pharmaceuticals Ltd is proud to become one of the 27 companies to sign licensing agreement with the Medicines Patent Pool (MPP)
Japan OKs Pfizer Covid-19 oral pills amid surging infections
Disposable Face Masks vs Reusable Face Masks
Surgical Face Masks V/S Respirators
How do Respirators Actually Work?
Type IIR Masks - How they are Manufactured ?
We can offer You Made In Uk Masks and competitive prices
Glenmark and SaNOtize introduce nasal spray to treat Covid-19 in India
India gives Việt Nam COVID-19 vaccines and raw materials to make COVID drugs
COVID-19 pills could spark scramble among nations
Square launches Molnupiravir in local mkt